• Eligard 22.5 mg

  Form: powder for solution for subcutaneous injection

  Active substance	Dosage
  leuprorelin	20.87 mg

  ATC: L02AE02

  Manufacturer: Tolmar Inc. (responsible for batch release; responsible for secondary packaging; responsible for manufacturing of syringe A, syringe B, final packaging and quality control; responsible for control/testing of the batch; responsible for control/testing of the batch)

• Eligard 45 mg

  Form: powder for solution for subcutaneous injection

  Active substance	Dosage
  leuprorelin	41.7 mg

  ATC: L02AE02

  Manufacturer: Tolmar Inc. (responsible for batch release; responsible for secondary packaging; responsible for manufacturing of syringe A, syringe B, final packaging and quality control; responsible for control/testing of the batch; responsible for control/testing of the batch)

• Eligard 7.5 mg

  Form: powder for solution for subcutaneous injection

  Active substance	Dosage
  leuprorelin	6.96 mg

  ATC: L02AE02

  Manufacturer: Tolmar Inc. (responsible for batch release; responsible for secondary packaging; responsible for manufacturing of syringe A, syringe B, final packaging and quality control; responsible for control/testing of the batch; responsible for control/testing of the batch)

• Leiprorelin sandoz®

  Form: implant

  Active substance	Dosage
  leuprorelin	5 mg

  ATC: L02AE02

  Manufacturer: Ever Pharma Jena GmbH (manufacturing "in bulk", packaging, batch release) / EVER Pharma Jena GmbH (secondary packaging, batch release)

• Leiprorelin-vista

  Form: implant

  Active substance	Dosage
  leuprorelin	10.72 mg

  ATC: L02AE02

  Manufacturer: AMV GmbH (production of finished dosage form, primary and secondary packaging, batch control, batch release)